Diego Ripamonti
Impact in
- Virology top 2%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 32
- HIV/AIDS Research and Interventions 21
- Virology 25
- HIV Research and Treatment 25
- Co-authors
- Franco Maggiolo (19 shared papers)Fredy Suter (12 shared papers)Fredy Suter (8 shared papers)Claudio Arici (11 shared papers)Annapaola Callegaro (6 shared papers)Marco Rizzi (8 shared papers)Giampietro Gregis (7 shared papers)Monica Airoldi (5 shared papers)
- Journals
- AIDS (9 papers)HIV Clinical Trials (6 papers)Clinical Infectious Diseases (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)Journal of Medical Virology (3 papers)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Diego Ripamonti
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Virology 377
- Infectious Diseases 734
- Emergency Medicine 202
- Hepatology 118
- Epidemiology 211
Countries citing papers authored by Diego Ripamonti
This map shows the geographic impact of Diego Ripamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Ripamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Ripamonti more than expected).
Fields of papers citing papers by Diego Ripamonti
This network shows the impact of papers produced by Diego Ripamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Ripamonti. The network helps show where Diego Ripamonti may publish in the future.
Co-authors
The 25 scholars most cited alongside Diego Ripamonti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 104 | |
| 2 | 2003 | 92 | |
| 3 | 2002 | 81 | |
| 4 | 2007 | 77 | |
| 5 | 2017 | 66 | |
| 6 | 2011 | 63 | |
| 7 | 2002 | 63 | |
| 8 | 2003 | 58 | |
| 9 | HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. | 2012 | 43 |
| 10 | 2009 | 41 | |
| 11 | 2011 | 37 | |
| 12 | 2017 | 30 | |
| 13 | 2020 | 29 | |
| 14 | 2013 | 29 | |
| 15 | 2015 | 28 | |
| 16 | 2022 | 26 | |
| 17 | 2003 | 26 | |
| 18 | 2015 | 24 | |
| 19 | 2010 | 23 | |
| 20 | 2001 | 23 |
About Diego Ripamonti
Diego Ripamonti is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Hepatology, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (32 papers), HIV Research and Treatment (25 papers), HIV/AIDS Research and Interventions (21 papers), HIV-related health complications and treatments (6 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers), Hepatitis C virus research (3 papers), Drug-Induced Adverse Reactions (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Virology (377 citations), Infectious Diseases (734 citations), Emergency Medicine (202 citations), Hepatology (118 citations) and Epidemiology (211 citations). Diego Ripamonti has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Franco Maggiolo, Fredy Suter, Fredy Suter, Claudio Arici, Annapaola Callegaro, Marco Rizzi, Giampietro Gregis, Monica Airoldi, Dario Cattaneo and Veronica Ravasio. Their work appears in journals such as AIDS, HIV Clinical Trials, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Journal of Medical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.